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Diabetes is associated with renal calcium and magnesium
wasting, but the molecular mechanisms of these defects are
unknown. We measured renal calcium and magnesium
handling and investigated the effects of diabetes on calcium
and magnesium transporters in the thick ascending limb and
distal convoluted tubule in streptozotocin (STZ)-induced
diabetic rats. Rats were killed 2 weeks after inducing
diabetes, gene expression of calcium and magnesium
transporters in the kidney was determined by real-time
polymerase chain reaction, and the abundance of protein
was assessed by immunoblotting. Our results showed that
diabetic rats had significant increase in the fractional
excretion for calcium and magnesium (both Po0.01), but not
for sodium. Reverse transcriptase-polymerase chain reaction
revealed significant increases in messenger RNA abundance
of transient potential receptor (TRP) V5 (223710%), TRPV6
(17779%), calbindin-D28k (23178%), and TRPM6 (16578%)
in diabetic rats. Sodium chloride cotransporter was also
increased (207710%). No change was found in paracellin-1
(cortex: 10878%; medulla: 110710%). Immunofluorescent
studies of renal sections showed significant increase in
calbindin-D28k (238710%) and TRPV5 (211710%), but no
changes in paracellin-1 in Western blotting (cortex: 11077%;
medulla: 9977%). Insulin administration completely
corrected the hyperglycemia-associated hypercalciuria and
hypermagnesiuria, and reversed the increase of calcium and
magnesium transporter abundance. In conclusion, our results
demonstrated increased renal calcium and magnesium
transporter abundance in STZ-induced diabetic rats, which
may represent a compensatory adaptation for the increased
load of calcium and magnesium to the distal tubule.
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It is well known that carbohydrate intake is associated with
increased renal calcium excretion.1 Furthermore, glucose
ingestion can augment both renal calcium and magnesium
excretion.2 Hypercalciuria is an early finding of uncontrolled
diabetes mellitus (DM) in humans and experimental
animals.3,4 The effect of DM on calcium metabolism is
complex, but essentially it is associated with a negative
calcium balance hallmarked by both bone and renal loss.3–5
The underlying mechanism contributing to diabetes-asso-
ciated renal calcium loss has been investigated extensively. In
addition to osmotic effect, a specific tubular defect in calcium
reabsorption, which leads to calcium loss, has been
proposed.6–8 Though most ultrafiltered calcium is reabsorbed
in the proximal tubules,9 previous microperfusion studies did
not reveal any decrease of calcium reabsorption in this
segment in diabetic animals.6–8 In fact, two sites have been
identified as having defect in calcium transport: the thick
ascending limb (TAL) of Henle’s loop and terminal nephron.6
Hypomagnesemia is a common complication of uncon-
trolled DM.10,11 Among factors contributing to hypomagne-
semia, renal magnesium loss is the major determinant.11
Similar to calcium, renal magnesium wasting is probably
because of defects in the TAL, where more than 50% of
ultrafiltered magnesium is reabsorbed.12 This is supported by
the finding that insulin stimulates magnesium transport in
microperfused mouse TAL.13 Intriguingly, the tubular defect
observed in diabetes does not affect all solutes equally.
Although glycosuria causes diuresis and natriuresis, urinary
excretion of calcium and magnesium is much greater than
that of other solutes.4 Therefore, it is likely that specific
calcium and magnesium transport molecules may be
involved in renal wasting of these minerals.
Recently, several calcium and magnesium transport
molecules were identified and specifically located in the
TAL or distal convoluted tubule (DCT).14–16 Paracellin-1, also
named as claudin-16 and as a member of claudin family, has
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been identified in the TAL and is responsible for paracellular
transport of calcium and magnesium.16 Dysfunction of the
paracellin-1 gene causes congenital hypomagnesemia with
hypercalciuria.17 In the DCT, transient potential receptor
(TRP) V5 and TRPV6 have been identified as calcium
channels, which finely tune the final urinary calcium
concentration.18 Another member of the TRP family,
TRPM6, is expressed in kidneys and intestines and is
responsible for transcellular magnesium absorption in the
DCT.19 Whether these transport molecules are involved in
the pathogenesis of diabetes-induced renal calcium and
magnesium wasting has not been studied. By investigating
the effects of diabetes on these molecules, we hope to explore
the molecular mechanisms involved in diabetes-associated
tubular defects in calcium and magnesium transports.
RESULTS
Diabetic rats had a 4–5-fold increase in daily urine output
compared to the control rats (Po0.01, Table 1). With insulin
treatment, which effectively reduced blood glucose levels, the
urinary output was normalized. There was no difference in
serum creatinine, sodium, calcium, magnesium, or phos-
phorous levels among the three groups. Venous blood pH
value was also similar among the three groups (pH, control:
7.4170.09; diabetic: 7.4270.03; diabetics with insulin
treatment: 7.4070.06, P40.05).
The calculated creatinine clearance was not different
between diabetic and control rats (Table 1). Daily urinary
excretion of sodium, calcium, and magnesium was markedly
increased in diabetic rats compared to that of the control
group. A two-fold increase in sodium excretion was found in
the diabetic group, whereas there was an eight-fold increase
in calcium and five-fold increase in magnesium excretion
(sodium: 1.7270.18 vs 0.8670.06 mmol/day/100 g; calcium:
2.8170.43 vs 0.3870.05 mg/day/100 g; magnesium: 3.827
0.38 vs 0.7770.15 mg/day/100 g, all Po0.01, Figure 1). In the
insulin-treated group, none of these incremental changes in
sodium, calcium, or magnesium were observed (P40.05).
The fractional excretion of sodium did not change
significantly in diabetic group (0.7870.09 vs 0.5870.07%,
P40.05, Figure 2a). There was significant increase in fraction
excretion of calcium and magnesium (Ca: 3.5970.58 vs
0.5670.08%; Mg: 19.1871.51 vs 4.9571.56%, both
Po0.01, Figure 2b and c). Insulin treatment not only
reduced the blood glucose level, but also reduced fraction
excretion of calcium and magnesium. As balance studies were
not performed, the increased daily urinary excretion, or
fractional excretion of calcium and magnesium, may be
because of increased intake of calcium and magnesium,
increased renal excretion of calcium and magnesium, or the
combination of the two. Nevertheless, these results suggest
that filtered load of calcium and magnesium was increased in
diabetic rats.
Messenger RNA expression
In diabetic rats, there was upregulation of TRPV5, TRPV6,
and calbindin-D28K genes compared to normal animals
(TRPV5: 223710%, TRPV6: 17779%, calbindin-D28k:
23178%, all Po0.05, Figure 3). The sodium chloride
cotransporter gene expression also increased significantly
(207710%, Po0.05). In the insulin-treated diabetic group,
no changes were found in gene expression (TRPV5:
10877%, TRPV6: 10278%, calbindin-D28k: 9879%,
sodium chloride cotransporter: 108712%, all P40.05).
Increased expression was also noted in TRPM6 in diabetic
rats (16578%, Po0.05), but not in the insulin-treated
Table 1 | Biochemical data of three groups of animals
Control Diabetes
Diabetes-insulin
treated
Body weight (g) 311.775.9 325.9712.3 290.278.6
Serum glucose (mg/dl) 105.476.3 441.6726.5* 141.3734.6
Serum Na (mmol/l) 13873.3 13672.9 13773.1
Serum Cr (mg/dl) 0.3570.02 0.4970.03 0.4370.02
Serum Ca (mg/dl) 9.870.1 9.570.2 10.270.1
Serum Mg (mg/dl) 1.970.2 1.970.1 1.870.1
Serum Pi (mg/dl) 7.970.6 7.870.9 7.671.0
Urine volume (ml/day) 40.072.6 133.9714.5* 34.0710.0
Creatinine clearance
(ml/24 h)
2.770.1 2.970.4 2.470.1
*Po0.05, diabetes vs control.
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Figure 1 | Daily urinary excretion of sodium (mmol/24 h/100 g),
calcium (mg/24 h/100 g), and magnesium (mg/24 h/100 g) in
three groups of rats: control (C), DM, and DMI. *Po0.01 compared
to the controls.
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Figure 2 | Fractional excretion (FE, %) of (a) sodium, (b) calcium,
and (c) magnesium in the three groups of rats: control (C),
DM, and DMI. *Po0.01 compared to the controls.
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diabetic group (10578%, P40.05). As the paracellin-1 is
expressed in the thick ascending limb of Henle, which
extends from the medulla to cortex, gene expression of
paracellin-1 was examined in both renal section tissues.
Paracellin-1 showed no change in the diabetic and insulin-
treated diabetic groups (cortex: diabetic: 10878%, insulin-
treated diabetic: 10274%, both P40.05; medulla: diabetic
110710%, insulin-treated diabetic: 10978%, P40.05).
Immunoblotting and immunofluorescent studies
To examine whether the effects on messenger RNA (mRNA)
expression were translated into the protein level, Western
blotting was performed. The abundance of calbindin-D28k
protein was increased significantly in diabetic rats compared
to the control group. This increase was not found in the
insulin-treated group (diabetic: 19878%, insulin-treated
diabetic: 10579%, Figure 4a). The study on protein
abundance of paracellin-1 did not show any significant
alternations both in the cortex and medulla (cortex: diabetic:
11077%, insulin-treated diabetic: 9876%, Figure 4b;
medulla: diabetic: 9977%, insulin-treated diabetic:
9578%, Figure 4c). The immunofluorescent staining study
revealed that there was significant increase in protein
expression of calbindin-D28k in diabetic rats and no change
in insulin-treated diabetics (diabetic: 238710%, insulin-
treated: 11877%, Figure 5a). The increased protein expres-
sion was also observed in TRPV5 (diabetic: 211710%,
insulin-treated: 10878%, Figure 5b).
DISCUSSION
Our results demonstrated that increased urinary calcium and
magnesium content in untreated DM is associated with
increased abundance of TRPV5, TRPV6, TRPM6, and
calbindin-D28K in the kidney. These physiological changes
and changes in gene expression are reversed by insulin
treatment. We did not find any significant changes in
paracellin mRNA or protein abundance in diabetic kidneys.
The TRPV5 is exclusively expressed in DCT and regarded
as a gate keeper for calcium entry in DCT.20 TRPV6 is
expressed in the DCT and the terminal nephron,21 but the
role of TRPV6 in renal calcium reabsorption is still
controversial in the literature. The TRPV5 knockout mice
demonstrated marked renal calcium wasting and reduced
bone mass.22 These findings suggest that renal TRPV6 is not
capable of compensating for the absence of TRPV5, or
alternatively TRPV6 in the DCT is dependent on TRPV5.
Calbindin-D28k is one of the important intracellular
calcium-binding proteins,23 and is expressed in DCT,
connecting tubule, and collecting duct in rat kidney.24 In
addition to facilitating intracellular calcium transport,
calbindin-D28k also acts as a buffer to avoid rapid increase
in intracellular calcium concentration, which leads to cell
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Figure 3 | Gene expression of (a) TRPV5, (b) TRPV6, (c) TRPM6,
(d) calbindin-D28k, (e) sodium chloride cotransporter (NCC), and
(f, cortex; g, medulla) paracellin-1 (PCLN-1) among the three
groups of rats: control (C), DM, and DMI. We used b-actin as the
reference gene. *Po0.05 compared to the controls.
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Figure 4 | Immunoblotting results for (a) calbindin-D28k and
(b, cortex; c, medulla) paracellin-1 for the three groups of
animals: control (C), DM, and DMI. Liver or spleen tissue was
selected as a negative control. The band of PCNL-1 was indicated by
an arrow based on its molecular weight of 35 kDa. *Po0.05
compared to the controls.
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toxicity.25,26 The lack of calbindin-D28k is associated with
significant renal calcium leak.27 Our findings of upregulation
of renal calbindin-D28k in diabetes is consistent with a
previous report, which demonstrated that renal calbindin-
D28k mRNA abundance increased 2–3-fold up to day 18 in
diabetic pregnant rats when compared to non-diabetic
pregnant rats.28 More recently, another study showed that
renal calbindin-D28k protein in diabetic rats was not different
from that in control rats.29 In this study, crude membrane
preparation from the kidney was used. As calbindin-D28k is a
cytosolic protein, it is possible that the amount of calbindin-
D28k was underestimated in the previous study.
The simultaneous increase in abundance of TRPV5,
TRPV6, and calbindin-D28k in diabetes-associated hyper-
calciuria suggests a coordinated response to increased
calcium load in urinary flow. Previous study on regulation
of renal epithelial calcium channel shows that calcium load is
an important factor regulating the expression of the apical
calcium channel.30 Interestingly, TRPV5, TRPV6, and
calbindin-D28k are known to be regulated by vitamin D. In
uncontrolled diabetes, the 1, 25 (OH)2 vitamin D3 level is signi-
ficantly reduced.29 It appears that in diabetic kidney, the effect
of calcium load may override the effect of vitamin D on gene
regulation of apical calcium channels and calcium-binding
protein.
In our study, although serum magnesium levels were not
decreased in diabetic rats for the 2-week duration, we were
able to demonstrate the upregulation of the TRPM6 gene in
diabetes-associated renal magnesium loss. Hypomagnesemia
may become evident with longer experimental durations. The
TRPM6 has been recognized as an important molecule
participating in intestinal and renal magnesium absorption.
In the kidney, the expression of TRPM6 is confined to the
DCT and colocalized with calbindin-D28k.19 More recently,
inhibition of TRPM6 was found as the etiology of Tacrolimus
(FK506)-related renal magnesium loss with resulting hypo-
magnesemia.31 In diabetes, the upregulation of TRPM6 may
be similar to that in TRPV5 and TRPV6 as a compensatory
mechanism to increased solute load. Similar compensatory
upregulation of transporters for sodium and water has been
reported previously.32 The sodium chloride cotransporter,
which is exclusively expressed in the DCT, also displayed
upregulation in our experiment. This result was consistent
with those of other studies.29,33 In addition, sodium–potas-
sium-chloride cotransporter in the thin ascending limb of
Henle, epithelial sodium channel in the connecting tubule
and collecting duct, and water channels, aquaporins in
collecting duct, all showed a compensatory increase in
diabetic animals to avoid excessive sodium or water loss.33,34
The TAL plays an important role in renal calcium and
magnesium reabsorption, primarily via the paracellular
transport.35,36 The reabsorption of calcium and magnesium
in TAL is a passive process, which is voltage- and load-
dependent. We did not find any significant changes in both
mRNA expression and protein abundance of paracellin-1 in
diabetic kidneys. As mentioned earlier, previous micropunc-
ture and microperfusion studies demonstrated calcium
reabsorption defect in the TAL in diabetic animals.6–8 Our
study has ruled out changes in paracellin-1 gene expression as
a possible cause of diabetes-associated TAL defect in renal
calcium and magnesium reabsorption. As insulin is known to
increase transepithelial potential difference (Vt) in TAL,13 it
is possible that the lack of insulin in diabetes may reduce Vt,
thus suppressing calcium and magnesium reabsorption. The
exact mechanism remains to be determined.
Adequate control of plasma glucose by insulin treatment
effectively reversed renal calcium and magnesium loss in our
study. This effect is accompanied by normalization of
increased calcium and magnesium transporter abundance.
Previous experiments showed that a 2-week delay of insulin
administration failed to reverse renal calcium loss in diabetic
animals. It was proposed that an irreversible tubular defect
might develop if diabetes is left untreated.37 Therefore, strict
and early glucose control is critical for preventing diabetes-
related disturbance in mineral metabolism.
In conclusion, our study is the first to demonstrate the
increased abundance of calcium and magnesium transport
molecules and binding protein in the DCT in experimentally
induced diabetes. It is likely that there is a common
compensatory mechanism shared by transporters for many
solutes in the diabetic kidney. In our study, diabetes does not
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Figure 5 | Immunofluorescent results for (a, original magnifica-
tion  100) calbindin-D28k and (b, original magnification  100)
TRPV5 for the three groups of animals: control (C), DM, and DMI.
*Po0.05 compared to the controls.
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affect the abundance of paracellin-1 in the kidney. The
mechanism of increased renal calcium and magnesium
excretion in the TAL remains unclear. Correction of
hyperglycemia with insulin not only reduces renal calcium
and magnesium excretion but also reverses the changes in
gene expression.
MATERIALS AND METHODS
Animals
Male Sprague–Dawley rats weighing 250–350 g were used for this
experiment. All rats were maintained under a constant 12-h
photoperiod at temperatures between 21 and 231C. They were
allowed free access to food and water. The food contained sodium
(0.33%), calcium (1.0%), and magnesium (0.16%). The animals
were divided into three groups: diabetic rats, control rats, and
insulin-treated diabetic rats.
Diabetic rats
Rats (n¼ 12) were rendered diabetic by streptozotocin (STZ, Sigma,
St Louis, MO, USA) at the dosage of 65 mg/kg via a single
intraperitoneal injection. STZ was freshly dissolved in citrate buffer
(pH 4.8) and maintained on ice until injection. Diabetes was
confirmed by the development of glycemia (X300 mg/dl glucose)
24 h after injection. As diabetic rats developed polyuria from
hyperglycemia, they were allowed to eat and drink ad lib in order to
avoid volume depletion, which is known to affect renal calcium and
magnesium reabsorption.
Control rats
Control rats (n¼ 10) received a citrate buffer injection alone. Blood
glucose levels were determined when the rats were killed.
Insulin-treated diabetic rats
Six rats were induced diabetic with STZ, and then received insulin
therapy (Ultratard HM, Novo Nordisk, Bagsvaerd, Denmark) via
subcutaneous injection daily for 2 weeks until they were killed. The
insulin dosage was adjusted daily to maintain blood glucose level in
the range of 100–200 mg/dl.
Biochemical studies
Urine samples (24-h) were collected from all the three groups of
animals using individualized metabolic cages. The rats were then
harvested and blood samples were used for biochemical measure-
ments. Serum and urinary creatinine, sodium, calcium, and
magnesium were measured. The levels of creatinine, sodium,
calcium, magnesium, and phosphorous were determined using the
SYNCHRON CX DELTA system (Beckman, Fullerton, CA, USA) by
various methods according to manufacturer’s operating protocol.
Then, 24 h urinary excretion of sodium, calcium, and magnesium
was calculated and presented as mg per 100 g of body weight. The
fractional excretion (FE) of sodium, calcium, and magnesium was
calculated by the standard method. Venous blood samples were sent
for blood gas analysis of each group of animals to evaluate their
acid–base status.
Molecular studies
RNA isolation and complementary DNA synthesis. Renal
cortex and medulla were dissected and total RNA was isolated from
each section using TRIZOL reagent (Invitrogen, Carlsbad, CA, USA).
Reverse transcription for complementary DNA synthesis was
performed using the reverse transcription system (Promega,
Madison, WI, USA).
Real-time polymerase chain reaction
The alternations in gene expression were quantified utilizing real-
time polymerase chain reaction. The emission signal was assessed
using the fluorescent dye SYBR Green (ABI, Foster city, CA, USA).
The molecules involved in calcium transport, including TRPV5,
TRPV6, and calbindin-D28k, were assessed in all three animal
groups. Gene expression of sodium chloride cotransporter was also
investigated. For magnesium transport, the TRPM6 and paracellin-1
genes were studied. The mRNA abundance of b-actin was used as
the internal reference for each gene evaluated. The synthesized
complementary DNA was then subjected to real-time polymerase
chain reaction using the ABI prism 7900 HT Sequence Detection
System (ABI, Foster City, CA, USA). The primer sequences of the
studied genes are listed in Table 2. To determine the gene expression,
genes investigated in the present study were calculated as
2ðbactin Cttarget gene CtÞ, where Ct represents the first cycle at which
the output signal exceeds the threshold signal.38 Polymerase chain
reaction of each gene was performed in triplicate to obtain a mean
value.39 The changes in gene expression are presented as percentages
of control animal values.
Immunoblotting study
Renal cortical and medullary sections were frozen at 801C and
then homogenized at 41C in protein lysis buffer solution containing
20 mM Tris-HCl (pH 7.4), 0.1% sodium dodecyl sulfate, 5-mM
ethylenediamine tetraacetate, 1% Triton X-100, and a protease
inhibitor cocktail tablet (Roche, Penzberg, Germany). After
centrifugation at 12 000 g for 10 min at 41C, the protein concentra-
tions were determined using bicinchoninic acid protein assays. The
protein samples were then run on 10% sodium dodecyl sulfate-
polyacrylamide gel electrophoresis for calbindin-D28k and para-
cellin-1, and were then transferred to nitrocellulose membranes.
b-Actin was used as the internal control in this study. After blocking
with 10% non-fat milk, the membrane was incubated with goat
anti-mouse calbindin-D28k monoclonal antibody (1:5000, Sigma)
for 16 h. Further washing in 5% blocking milk was performed and
the membrane was incubated with goat anti-rabbit antibody
conjugated with horseradish peroxidase (1:30 000) for 3 min. Rabbit
anti-human paracellin-1 monoclonal antibody (1:500, Alpha
Diagnostics International, San Antonio, TX, USA) was used as
primary antibody for paracellin-1 detection, with incubation for
16 h. The abundance of studied protein was then quantified by
densitometric analyses. The changes in protein abundance are
presented as percentages of control animal values.
Table 2 | Lists of primers used for real-time PCR
Gene Forward primer Reverse primer
b-actin agtaccccattgaacacggc ttttcacggttggccttagg
CBD28K ggagctgcagaacttgatcc gcagcaggaaattctcttcg
NCC gaacggcacacccattgtaga gccttggactcccactccat
TRPV5 tgtttaccgccccctcaag cacagccccaatgactgtca
TRPV6 atccgccgctatgcaca agtttttctcctgagtctttttcca
TRPM6 aaagccatgcgagttatcagc cttcacaatgaaaacctgccc
PCLN-1 cagatgcgagtgcctgtga agcaccgcaaagagagtgaga
CBD28K, calbindin-D28k; NCC, sodium chloride cotransporter; PCLN-1, paracellin-1;
TRPV5, TRPV6 and TRPM6, transient receptor potential V5, V6, and M6.
1790 Kidney International (2006) 69, 1786–1791
o r i g i n a l a r t i c l e C-T Lee et al.: Renal Ca and Mg transporters in diabetes
Immunofluorescence microscopy
Paraffin-embedded kidney cortex tissue was used for calbindin-
D28k and TRPV5 protein assessment in three groups of animals.
Sections of 5 mm thickness were fixed with 4% paraformaldehyde for
15 min and incubated with primary antibody (goat anti-mouse
calbindin-D28k monoclonal antibody 1:500, Sigma, and rabbit anti-
rat ECaC1 1:100, Alpha Diagnostic International, San Antonio, TX,
USA) for 16 h, and then with fluorescein isothiocyanate-conjugated
secondary antibodies for calbindin-D28k (Jackson ImmunoResearch
Laboratories, Inc., West Grove, PA, USA), and streptavidin/fluores-
cein isothiocyanate-conjugated secondary antibody for TRPV5
(DakoCytomation, Dako Corporation, Carpinteria, CA, USA) for
30 min. The immunofluorescence pictures were then taken using a
Zeiss fluorescence microscope connected with a digital photo camera
(Evolution VF, MediaCybernetics, Silver Spring, MD, USA). Semi-
quantitative determination of the protein expression was performed
with the Image-Pro Plus 5.0 image analysis software. Amount of
protein was expressed as the mean of integrated optimal density. The
alternation is expressed as percentage of control animal value.39
Statistical analyses
Data are presented as means7s.e.m. Statistical analyses of the data
were performed using SPSS-PC software. Unpaired Student’s t-tests
were used to compare differences between two groups. To determine
the significant difference among controls, diabetic, and insulin-
treated diabetic rats, one-way analysis of variance and Tukey’s test
were used. A P-value of o0.05 was considered statistically
significant for all tests.
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